Table 3.
Mean (SE) duration of patient reported participation in physical activities outside of the pulmonary rehabilitation program in the treatment groups
| Tiotropium |
Placebo* |
|||||||
|---|---|---|---|---|---|---|---|---|
| n | Time (min) | ΔWeek 4 (min) | p-value for ΔWeek 4 | n | Time (min) | ΔWeek 4 (min) | p-value for ΔWeek 4 | |
| Prior to PR (week 4) | 25 | 279 (41) | – | – | 21 | 253 (50) | – | – |
| During PR (week 9) | 25 | 322 (39) | 43 (53) | 0.425 | 17 | 349 (74) | 110 (85) | 0.212 |
| End of PR (week 13) | 22 | 403 (81) | 145 (84) | 0.098 | 16 | 353 (100) | 66 (96) | 0.506 |
| Follow-up (week 17) | 22 | 526 (75) | 269 (63) | <0.001 | 16 | 355 (102) | 99 (106) | 0.369 |
| Follow-up (week 21) | 19 | 432 (59) | 159 (58) | 0.013 | 17 | 394 (97) | 125 (108) | 0.266 |
| Follow-up (week 25) | 22 | 562 (86) | 262 (96) | 0.013 | 16 | 346 (95) | 60 (93) | 0.529 |
Abbreviations: PR, pulmonary rehabilitation.
*
Note: p > 0.05 for between group differences.